Pharmaceuticals, Biotechnology and Life Sciences
Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory DiseasesSAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) —…
SAN DIEGO and TORONTO, March 09, 2023 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision…
SOUTH SAN FRANCISCO, Calif., March 09, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company…
– Positive data from bexotegrast INTEGRIS-IPF 320 mg dose group demonstrated a continued favorable safety profile and statistically significant increases…
Exploring strategic partnership options to advance AMT-101 for chronic pouchitis, an orphan indication with no FDA-approved products Evaluating next steps for…
Both doses of BNC210 as an acute treatment resulted in reductions in anxiety across multiple phases of the public speaking…
ROCKVILLE, MD, March 08, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing…
Quoin announced dosing of first patient in double blinded clinical study to evaluate QRX003 for Netherton SyndromeQuoin announced initiation of…
TORONTO, Ontario and CAMBRIDGE, Massachusetts, March 08, 2023 (GLOBE NEWSWIRE) — Completed all preclinical studies and manufacturing to support PMN310…
– Nirogacestat Treatment Significantly Improved Progression-Free Survival, Objective Response Rate and Key Patient Reported Outcomes – – New Drug Application…